bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
GLUCR

Order Name:
Non-FBG*

 
Useful For:
Diagnosing and managing diabetes mellitus and other carbohydrate metabolism disorders including gestational diabetes, neonatal hypoglycemia, idiopathic hypoglycemia, and pancreatic islet cell carcinoma
 
Methodology:
 Hexokinase/G-6-PDH
 
AliasesName:
Non Fasting  Blood Glucose
 
 
 
Test Code:
GLUCR

Order Name:
Non-FBG*

 
Collection Specimen Or Container:
Blood/ Plain blood (Red top) 6 mL, 1 tube
 
Specimen Testing Type:
Serum, minimum volume 0.5 mL
 
Sub Mission Container:
Plastic vial
 
Rejection Criteria:
Hemolysis: 4+ reject
Lipemia: 4+ reject
Icterus: 4+ reject
 
 
 
Test Code:
GLUCR

Order Name:
Non-FBG*

 
Schedule:
Tested Daily (24 Hours)
 
Turnaround Time:
Specimen collected to reported within 1:30 Hours (90 Mins)
 
Performing Location:
Chemistry, Laboratory Department Tel. 13224
 
Specimen Retention Time:
5 days
 
 
 
Test Code:
GLUCR

Order Name:
Non-FBG*

 
 
Clinical Information:
Blood glucose determinations are the most frequently performed clinical chemistry laboratory procedures, commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels (hyperglycemia) may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyperfunction as well as other disorders. Decreased glucose levels (hypoglycemia) may result from excessive insulin therapy or various liver diseases.
 
Interpretation:
Any of the following results, confirmed on a subsequent day, can be considered diagnostic for diabetes:
  • Fasting plasma or serum glucose > or =126 mg/dL after an 8-hour fast
  • 2-Hour plasma or serum glucose > or =200 mg/ dL during a 75-gram oral glucose tolerance test (OGTT)
  • Random glucose >200 mg/dL, plus typical symptoms

Patients with "impaired" glucose regulation are those whose fasting serum or plasma glucose fall between 101 and 126 mg/dL, or whose 2-hour value on oral glucose tolerance test fall between 140 and 199 mg/dL. These patients have a markedly increased risk of developing type 2 diabetes and should be counseled for lifestyle changes and followed up with more testing. Indications for screening and testing include strong family history, marked obesity, history of babies over 9 pounds, and recurrent skin and genitourinary infections.

Glucose levels of 25 mg/dL or lower in infants younger than 1 week are considered to be potentially life threatening, as are glucose levels of 40 mg/dL or lower in infants older than 1 week.

Glucose levels of 400 mg/dL and higher are considered a critical value.
 
Clinical Reference:
  1. Manufacturer’s reagent package insert, Architect® Glucose Abbott Laboratories, Abbott Park IL 60064 USA, October 2012.
  2. http://www.diabetes.org/diabetes-basics/diagnosis(Retrieved: June 2018)
  3. http://www.mayomedicallaboratories.com (Retrieved: 01 Jan 2019)